Author

Laimas Virginijus Jonaitis

HELICOBACTER PYLORIDIAGNOSTIC TESTS USED IN 35,000 PATIENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)
HELICOBACTER PYLORIDIAGNOSTIC TESTS USED IN 35,000 PATIENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis

TRENDS IN THE PRESCRIPTION OF EMPIRICAL TREATMENTS AND THEIR EFFECTIVENESS IN NAÏVE PATIENTS OVER 10 YEARS (2013-2022) IN EUROPE: DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
TRENDS IN THE PRESCRIPTION OF EMPIRICAL TREATMENTS AND THEIR EFFECTIVENESS IN NAÏVE PATIENTS OVER 10 YEARS (2013-2022) IN EUROPE: DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

PREVALENCE OF HELICOBACTER PYLORI DECREASED SIGNIFICANTLY DURING THE LAST 25 YEARS AMONG LITHUANIAN MEDICAL STUDENTS
PREVALENCE OF HELICOBACTER PYLORI DECREASED SIGNIFICANTLY DURING THE LAST 25 YEARS AMONG LITHUANIAN MEDICAL STUDENTS

Laimas Virginijus Jonaitis  et al.

MICROBIOME ANALYSIS OF GASTRIC CANCER TISSUE AT DNA AND RNA LEVELS
MICROBIOME ANALYSIS OF GASTRIC CANCER TISSUE AT DNA AND RNA LEVELS

Laimas Virginijus Jonaitis  et al.

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2021: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2021: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

EFFECTIVENESS AND SAFETY OF HIGH-DOSE DUAL THERAPY: RESULTS OF THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS AND SAFETY OF HIGH-DOSE DUAL THERAPY: RESULTS OF THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)
FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS DURING THE PERIOD 2013-2022: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS DURING THE PERIOD 2013-2022: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

LONG-TERM CULTURING OF HEALTHY- AND ULCERATIVE COLITIS-PATIENT DERIVED COLON ORGANOIDS IS ASSOCIATED WITH DECREASED METHYLATION LEVEL OF LINE-1
LONG-TERM CULTURING OF HEALTHY- AND ULCERATIVE COLITIS-PATIENT DERIVED COLON ORGANOIDS IS ASSOCIATED WITH DECREASED METHYLATION LEVEL OF LINE-1

Laimas Virginijus Jonaitis  et al.

LONG NON-CODING RNA POLYMORPHISMS AND RISK OF GASTRIC CANCER AND ATROPHIC GASTRITIS
LONG NON-CODING RNA POLYMORPHISMS AND RISK OF GASTRIC CANCER AND ATROPHIC GASTRITIS

Laimas Virginijus Jonaitis  et al.

MICRORNA PROFILING ON THE LEVELS OF COLON TISSUE AND EPITHELIAL CELL-POPULATIONS IN PATIENTS WITH ACTIVE AND INACTIVE ULCERATIVE COLITIS
MICRORNA PROFILING ON THE LEVELS OF COLON TISSUE AND EPITHELIAL CELL-POPULATIONS IN PATIENTS WITH ACTIVE AND INACTIVE ULCERATIVE COLITIS

Laimas Virginijus Jonaitis  et al.

SKIN LESIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS IN UNIVERSITY HOSPITAL
SKIN LESIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS IN UNIVERSITY HOSPITAL

Laimas Virginijus Jonaitis  et al.

ROLE OF THE PROTON PUMP INHIBITORS IN HELICOBACTER PYLORI ERADICATION: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF THE PROTON PUMP INHIBITORS IN HELICOBACTER PYLORI ERADICATION: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES
EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES

Laimas Virginijus Jonaitis  et al.

EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

ROLE OF PROTON PUMP INHIBITORS DOSAGE IN THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF PROTON PUMP INHIBITORS DOSAGE IN THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

PRESCRIPTION PATTERN OF PROBIOTICS AS AN ADJUVANT THERAPY FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
PRESCRIPTION PATTERN OF PROBIOTICS AS AN ADJUVANT THERAPY FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Laimas Virginijus Jonaitis  et al.

Item 1 - 20 / 38
1
2